Page last updated: 2024-11-01

nitrendipine and Deficiency, Folic Acid

nitrendipine has been researched along with Deficiency, Folic Acid in 1 studies

Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"Nitrendipine is an experimental calcium channel blocking agent that also appears to cause the side effect of drug-induced gingival hyperplasia."5.28Nitrendipine-induced gingival hyperplasia. First case report. ( Bottomley, WK; Brown, RS; Corio, R; Sein, P, 1990)
"Nitrendipine is an experimental calcium channel blocking agent that also appears to cause the side effect of drug-induced gingival hyperplasia."1.28Nitrendipine-induced gingival hyperplasia. First case report. ( Bottomley, WK; Brown, RS; Corio, R; Sein, P, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, RS1
Sein, P1
Corio, R1
Bottomley, WK1

Other Studies

1 other study available for nitrendipine and Deficiency, Folic Acid

ArticleYear
Nitrendipine-induced gingival hyperplasia. First case report.
    Oral surgery, oral medicine, and oral pathology, 1990, Volume: 70, Issue:5

    Topics: Aged; Enzyme Activation; Folic Acid Deficiency; Gingival Hyperplasia; Humans; Hypertension; Male; Ni

1990